On Monday, Kura Oncology Inc (NASDAQ: KURA) opened higher 5.51% from the last session, before settling in for the closing price of $16.88. Price fluctuations for KURA have ranged from $7.98 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -17.20% at the time writing. With a float of $64.93 million, this company’s outstanding shares have now reached $74.35 million.
The extent of productivity of a business whose workforce counts for 142 workers is very important to gauge. In terms of profitability, gross margin is 31.81%, operating margin of -15450.39%, and the pretax margin is -14311.02%.
Kura Oncology Inc (KURA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Kura Oncology Inc is 15.28%, while institutional ownership is 91.05%. The most recent insider transaction that took place on May 20 ’24, was worth 57,916. In this transaction Chief Legal Officer of this company sold 2,615 shares at a rate of $22.15, taking the stock ownership to the 68,979 shares. Before that another transaction happened on Jan 29 ’24, when Company’s SVP, Finance & Accounting sold 2,318 for $17.80, making the entire transaction worth $41,262. This insider now owns 48,093 shares in total.
Kura Oncology Inc (KURA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -17.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Check out the current performance indicators for Kura Oncology Inc (KURA). In the past quarter, the stock posted a quick ratio of 14.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -2.62 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
The latest stats from [Kura Oncology Inc, KURA] show that its last 5-days average volume of 0.62 million was inferior to 0.89 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.78%. Additionally, its Average True Range was 0.70.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 18.77%, which indicates a significant decrease from 65.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.96% in the past 14 days, which was lower than the 37.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.99, while its 200-day Moving Average is $20.14. Now, the first resistance to watch is $18.24. This is followed by the second major resistance level at $18.66. The third major resistance level sits at $19.47. If the price goes on to break the first support level at $17.00, it is likely to go to the next support level at $16.19. The third support level lies at $15.76 if the price breaches the second support level.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
There are currently 76,634K shares outstanding in the company with a market cap of 1.38 billion. Presently, the company’s annual sales total 0 K according to its annual income of -152,630 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -50,840 K.
